E-LIB Suche - Ergebnisse für: Murgioni, S.

1

451P Assessment of PD-L1 on matched surgical specimen and b..:

Nappo, F. ; Ricagno, G. ; Ceccon, C....
Annals of Oncology. 35 (2024) - p. S181 , 2024

Link: https://doi.org/10.1016/..

2

53P Trifluridine/tipiracil plus capecitabine and bevacizuma..:

Ciracì, P. ; Conca, V. ; Moretto, R....
Annals of Oncology. 35 (2024) - p. S25-S26 , 2024

Link: https://doi.org/10.1016/..

3

423P Multicentre, multi-cohort, single-arm phase II trial o..:

Raimondi, A. ; Lonardi, S. ; Murgioni, S....
Annals of Oncology. 35 (2024) - p. S172 , 2024

Link: https://doi.org/10.1016/..

4

443P TRIfluridine vs FOLfiri in thIrd-Line Metastatic gastr..:

Perissinotto, E. ; Cerantola, R. ; De Grandis, M.C....
Annals of Oncology. 35 (2024) - p. S178 , 2024

Link: https://doi.org/10.1016/..

5

113P p16 immunohistochemical (IHC) expression (exp) predict..:

Studiale, V. ; Germani, M.M. ; Moretto, R....
Annals of Oncology. 35 (2024) - p. S53 , 2024

Link: https://doi.org/10.1016/..

6

Genetic variants of DNA repair-related genes predict effica..:

Suenaga, M. ; Schirripa, M. ; Cao, S....
Annals of Oncology. 28 (2017) 5 - p. 1015-1022 , 2017

Link: https://doi.org/10.1093/..

7

Upfront FOLFOXIRI plus bevacizumab and reintroduction after..:

Cremolini C ; Antoniotti C ; Rossini D...
info:eu-repo/semantics/altIdentifier/pmid/32164906. , 2020

Link: http://hdl.handle.net/11..

8

Upfront FOLFOXIRI plus bevacizumab and reintroduction after..:

Cremolini C ; Antoniotti C ; Rossini D...
info:eu-repo/semantics/altIdentifier/pmid/32164906. , 2020

Link: http://hdl.handle.net/24..

9

Prognostic impact of the cumulative dose and dose intensity..:

Berardi R ; Torniai M ; Pusceddu S...
info:eu-repo/semantics/altIdentifier/pmid/28547856. , 2017

Link: http://hdl.handle.net/11..

10

prediction of overall survival with 2nd line l2os chemother..:

C. Neuzillet ; A. Casadei Gardini ; B. Brieau...
url:https://www.openaccessrepository.it/communities/itmirror. , 2018

Link: https://www.openaccessre..

11

lba20tribe2 a phase iii randomized strategy study by gono i..:

C. Cremolini ; C. Antoniotti ; S. Lonardi...
url:https://www.openaccessrepository.it/communities/itmirror. , 2018

Link: https://www.openaccessre..

12

advanced intrahepatic cholangiocarcinoma icca treated with ..:

V. Dadduzio ; M.D. Rizzato ; G. Ramondo...
url:https://www.openaccessrepository.it/communities/itmirror. , 2018

Link: https://www.openaccessre..

13

development of a new clinical nomogram including velocity r..:

E. Dell'Aquila ; F. Pantano ; D. Rossini...
url:https://www.openaccessrepository.it/communities/itmirror. , 2018

Link: https://www.openaccessre..

14

Prognostic impact of the cumulative dose and dose intensity..:

R. Berardi ; M. Torniai ; S. Pusceddu...
info:eu-repo/semantics/altIdentifier/pmid/28547856. , 2017

Link: http://hdl.handle.net/24..